Rosario García‐Vicuña

Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial

José María Álvaro‐Gracia, Juan Ángel Jover, Rosario García‐Vicuña et al. · Annals of the Rheumatic Diseases · 2016 · 261 citations

IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study

José María Galván‐Román, S. C. Rodriguez-García, Emilia Roy‐Vallejo et al. · Journal of Allergy and Clinical Immunology · 2020 · 231 citations · Full text

Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis.

A Laffón, Rosario García‐Vicuña, Alicia Humbría et al. · Journal of Clinical Investigation · 1991 · 204 citations · Full text

Inflammation, Rheumatology, Sf T Cells +15

CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast‐like synoviocytes from rheumatoid arthritis patients

Rosario García‐Vicuña, María Victoria Gómez‐Gaviro, María Jesús Domínguez‐Luis et al. · Arthritis & Rheumatism · 2004 · 171 citations

Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study

Antonio Fernández‐Nebro, JL Marenco de la Fuente, Luis Carreño et al. · Lupus · 2012 · 113 citations · Full text